Trial Profile
A Randomized Phase II Clinical Trial of Nab-Paclitaxel and Carboplatin Compared With Gemcitabine and Carboplatin as First-line Therapy in Advanced Squamous Cell Carcinoma of Lung
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Gemcitabine
- Indications Lung cancer
- Focus Therapeutic Use
- 07 Feb 2019 Results published in the European Journal of Cancer
- 04 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 30 May 2014 Primary endpoint 'objective response rate' not met.